Schedule 13G ownership disclosure

Maze Therapeutics Inc

Common Stock, par value $0.001 per share · CUSIP: 578784100

Event date: 2025-02-03

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Frazier Life Sciences Public Fund, L.P.

    Shares: 2,376,329.00 · Class: 5.4%

  • FHMLSP, L.P.

    Shares: 2,376,329.00 · Class: 5.4%

  • FHMLSP, L.L.C.

    Shares: 2,376,329.00 · Class: 5.4%

  • Frazier Life Sciences Public Overage Fund, L.P.

    Shares: 701,164.00 · Class: 1.6%

  • FHMLSP Overage, L.P.

    Shares: 701,164.00 · Class: 1.6%

  • FHMLSP Overage, L.L.C.

    Shares: 701,164.00 · Class: 1.6%

  • Frazier Life Sciences X, L.P.

    Shares: 41,719.00 · Class: 0.1%

  • FHMLS X, L.P.

    Shares: 41,719.00 · Class: 0.1%

  • FHMLS X, L.L.C.

    Shares: 41,719.00 · Class: 0.1%

  • Frazier Life Sciences XI, L.P.

    Shares: 74,688.00 · Class: 0.2%

  • FHMLS XI, L.P.

    Shares: 74,688.00 · Class: 0.2%

  • FHMLS XI, L.L.C.

    Shares: 74,688.00 · Class: 0.2%

  • James N. Topper

    Shares: 3,193,900.00 · Class: 7.3%

  • Patrick J. Heron

    Shares: 3,193,900.00 · Class: 7.3%

  • Albert Cha

    Shares: 3,077,493.00 · Class: 7.0%

  • James Brush

    Shares: 3,077,493.00 · Class: 7.0%

  • Daniel Estes

    Shares: 74,688.00 · Class: 0.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001415889-25-003423
Form type
SCHEDULE 13G
Filer
Frazier Life Sciences Public Fund, L.P.
CIK
CIK 1863769
Filed
Feb 10, 2025
Reporting period
Feb 03, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub